Literature DB >> 14071356

SURVIVAL OF STAPHYLOCOCCUS AUREUS IN THE ENVIRONMENT. I. EXPOSURE OF SURFACES.

J J MCDADE, L B HALL.   

Abstract

Entities:  

Keywords:  AIR MICROBIOLOGY; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; HUMIDITY; STAPHYLOCOCCUS; TEMPERATURE

Mesh：

Year:  1963        PMID： 14071356     DOI： 10.1093/oxfordjournals.aje.a120352

Source DB:  PubMed          Journal:  Am J Hyg        ISSN： 0096-5294


× No keyword cloud information.
  8 in total

1.  THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION.

Authors:  J A REINARZ; A K PIERCE; B B MAYS; J P SANFORD
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

Review 2.  MRSA and the environment: implications for comprehensive control measures.

Authors:  N Cimolai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-14       Impact factor: 3.267

3.  Survival of Yersinia pestis on environmental surfaces.

Authors:  Laura J Rose; Rodney Donlan; Shailen N Banerjee; Matthew J Arduino
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

4.  [Studies on the differentiation of epidemic and non-epidemic staphylococci. II. Survival of staphylococci in dry and humid environments].

Authors:  G Pulverer; W Bruns
Journal:  Z Med Mikrobiol Immunol       Date:  1969

5.  Viability of hospital staphylococci in air.

Authors:  K C Strasters; K C Winkler
Journal:  Bacteriol Rev       Date:  1966-09

6.  Effect of physiological age and state on survival of desiccated Pseudomonas aeruginosa.

Authors:  P Skaliy; R G Eagon
Journal:  Appl Microbiol       Date:  1972-11

7.  Survival of bacteria on metal surfaces.

Authors:  T R Wilkinson
Journal:  Appl Microbiol       Date:  1966-05

8.  Busting biofilms: free-living amoebae disrupt preformed methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium bovis biofilms.

Authors:  Kevin H Martin; Grace I Borlee; William H Wheat; Mary Jackson; Bradley R Borlee
Journal:  Microbiology (Reading)       Date:  2020-05-27       Impact factor: 2.777
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.